Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post-marketing Surveillance Study of the Occurrence of Serious Adverse Reactions Among Patients Who Receive Optison in Routine Medical Practice

NCT00730964 is registered in ClinicalTrials.gov with GE Healthcare as lead sponsor.

NCT NCT00730964
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00730964 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post-marketing Surveillance Study of the Occurrence of Serious Adverse Reactions Among Patients Who Receive Optison in Routine Medical Practice
Lead sponsor
GE Healthcare
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2008
Completion date
October 31, 2009
Enrollment
1,039 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

echocardiography